PharmaEngine, Inc. (TPEX:4162)
Taiwan · Delayed Price · Currency is TWD 66.40
-1.00 (-1.48%)
Jul 16, 2026, 1:30 PM CST
PharmaEngine Market Cap
PharmaEngine has a market cap or net worth of 9.68 billion as of July 16, 2026. Its market cap has decreased by -14.36% in one year.
Market Cap
9.68B
Enterprise Value
4.75B
Revenue
963.83M
Ranking
n/a
PE Ratio
23.00
Stock Price
66.40
Market Cap Chart
Since September 1, 2011, PharmaEngine's market cap has increased from 5.38B to 9.68B, an increase of 80.04%. That is a compound annual growth rate of 4.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 9.68B | -4.26% |
| Dec 31, 2025 | 10.11B | -22.04% |
| Dec 31, 2024 | 12.97B | -14.41% |
| Dec 29, 2023 | 15.16B | -15.60% |
| Dec 30, 2022 | 17.96B | 75.96% |
| Dec 30, 2021 | 10.21B | 21.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TCM Biotech International | 14.70B |
| EirGenix | 14.33B |
| Gongwin Biopharm Holdings | 13.15B |
| AP Biosciences | 10.86B |
| Polaris Group | 10.75B |
| Tanvex BioPharma | 10.65B |
| Locus Cell | 8.60B |
| Acepodia | 7.61B |